| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.44 | 4e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |